ライフサイエンスコーパス: thyronine

1 oxine (T4; 10(-7) mol/L) or 3,5,3'-triiodo-l-thyronine (10(-9) mol/L).

2 ater than 100 microM included 3',5'-diiodo-L-thyronine (3',5'-l-T2), 3-iodo-L-thyronine (L-T1), 3'-io

3 -l-T2), 3-iodo-L-thyronine (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-thyronine (L-T0).

4 othyronine (reverse T3; r-T3), 3,3'-diiodo-L-thyronine (3,3'-l-T2) and 3,5-diiodo-L-thyronine (3,5-D-

5 diiodo-l-thyronine (3,5-T(2)), 3,3'-diiodo-l-thyronine (3,3'-T(2)), and 3-iodo-l-thyronine (3-T(1)),

6 odo-L-thyronine (3,3'-l-T2) and 3,5-diiodo-L-thyronine (3,5-D-T2).

7 5'-triiodo-l-thyronine (rT(3)), 3,5-diiodo-l-thyronine (3,5-T(2)), 3,3'-diiodo-l-thyronine (3,3'-T(2)

8 diiodo-l-thyronine (3,3'-T(2)), and 3-iodo-l-thyronine (3-T(1)), in the brain and thyroid gland (TG)

9 tatively identified metabolite (3-monoiodo-l-thyronine 4-O-sulfate), and an unidentified feature (590

10 s of two thyroxine analogs, 3,3',5-triiodo-L-thyronine and 3,3',5-triiodothyroacetic acid, on purifie

11 Inhibiting 3,5,3'-tri-iodo-L-thyronine and 3,5,3',5'-tetra-iodo-L-thyronine secretion

12 ycholate, 5-leuenkephalin, triiodothyronine, thyronine, dabsyl-L-valine, and N-benzoyl-L-arginyl-4-am

13 iral forms of thyroxine, diiodotirosine, and thyronine in human milk, with potential implications for

14 (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-thyronine (L-T0).

15 5'-diiodo-L-thyronine (3',5'-l-T2), 3-iodo-L-thyronine (L-T1), 3'-iodo-L-thyronine (3'-L-T1), and L-t

16 arkedly decreased serum T3 (3,3 ,5-triiodo-l-thyronine), maternal hepatotoxicity, and increased multi

17 the 5'-position (DIBRT, GC-14) of the outer thyronine ring or from the bridging carbon (HY-4).

18 riiodo-l-thyronine (T(3)), 3,3',5'-triiodo-l-thyronine (rT(3)), 3,5-diiodo-l-thyronine (3,5-T(2)), 3,

19 yl derivatives sharing the GC-1 halogen-free thyronine scaffold.(4) One compound (NH-3) is a T(3) ant

20 -iodo-L-thyronine and 3,5,3',5'-tetra-iodo-L-thyronine secretion did not alter isoform switching, sug

21 shown that the late-term rise in tri-iodo-l-thyronine (T(3) ) in fetal sheep leads to the inhibition

22 the effects of MB07811 with 3,5,3'-triiodo-l-thyronine (T(3)) and a non-liver-targeted TR agonist, 3,

23 Tri-iodo-l-thyronine (T(3)) suppresses the proliferation of near-te

24 ix THs, l-thyroxine (T(4)), 3,3',5-triiodo-l-thyronine (T(3)), 3,3',5'-triiodo-l-thyronine (rT(3)), 3

25 were performed in control, 10-day triiodo-l-thyronine (T(3))-treated (model of increased UCP3 expres

26 he hormones, estradiol, and 3,3',5-triiodo-l-thyronine (T(3)).

27 Plasma thyroid hormone (tri-iodo-l-thyronine; T(3) ) concentrations rise near the end of ge

28 (-54%), adiponectin (-49%), 3,5,3'-tri-iodo-thyronine (T3) (-39%), and testosterone (-11%).

29 The thyroid hormone 3,5,3'-triiodo-L-thyronine (T3) and T4 were equipotent stimulators of PCN

30 Thyroid hormones such as 3,3',5 triiodo-L-thyronine (T3) control numerous aspects of mammalian dev

31 3,5,3'-triiodi-l-thyronine (T3) had a greater effect on increasing HR in

32 t has been shown to undergo 3,3',5-triiodo-L-thyronine (T3) induced conformational changes.

33 The thyroid hormone 3,3',5-triiodo-l-thyronine (T3) is essential for growth, differentiation,

34 Tri-iodo-L-thyronine (T3) treatment of cultured cardiomyocytes for

35 xisome proliferators (PPs), 3,3',5-triiodo-L-thyronine (T3), and 9-cis retinoic acid (9-cis RA) induc

36 d the role of the hormone, 3,3', 5-triiodo-L-thyronine (T3), in the nuclear translocation and targeti

37 orted that thyroid hormone, 3,3',5-triiodo-l-thyronine (T3), increased Na,K-ATPase activity of adult

38 nteractions with the ligand 3,3',5 triiodo-l-thyronine (T3), RXR, DNA, and co-activators such as SRC1

39 omparing the repertoires of 3,3',5-triiodo-L-thyronine (T3)-responsive genes of two neural cell lines

40 sed thyroid hormone levels (3,3',5-triiodo-l-thyronine [T3]).

41 hormones (L-thyroxine, T4; 3,5,3'-triiodo-L-thyronine, T3) and is overexpressed in ovarian cancer.

42 igated how thyroid hormone (3,5',5-triiodo-l-thyronine, T3) inhibits binding of thyroid hormone recep

43 esponse to thyroid hormone (3,5,3'-triiodo-l-thyronine, T3) is a dynamic and cell-type specific proce

44 Thyroid hormone (3,5,3'-triiodo-L-thyronine, T3) is an endocrine hormone that exerts homeo

45 0.24 mM, whereas thyroid hormone (triiodo-L-thyronine, T3) stabilizes an inactive monomeric form of

46 onine (TT(3)), and total 3,3',5'-triiodo-(L)-thyronine (TrT(3))] measured in human breast milk.

47 -thyroxine (TT(4)), total 3,3',5-triiodo-(L)-thyronine (TT(3)), and total 3,3',5'-triiodo-(L)-thyroni

48 loro-4,4'-biphenyldiol, and 3,3',5-triiodo-l-thyronine were determined.

49 ind triiodothyronine (T(3), 3,5,3'-triiodo-l-thyronine) with high affinity, and its precursor thyroxi

50 ursor thyroxine (T(4), 3,5,3',5'-tetraiodo-l-thyronine) with lower affinity.